» Articles » PMID: 28125810

Insights from Screening a Racially and Ethnically Diverse Population for Chronic Kidney Disease

Overview
Journal Am J Nephrol
Publisher Karger
Specialty Nephrology
Date 2017 Jan 27
PMID 28125810
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The value of chronic kidney disease (CKD) screening in the general population remains unclear but may be beneficial in populations with high disease prevalence. We examined risk factors for albuminuria among participants in a state-wide CKD screening program in Hawaii.

Methods: The National Kidney Foundation of Hawaii Kidney Early Detection Screening (NKFH-KEDS) program held 19 CKD screening events from 2006 to 2012. Participants rotated through 5 stations during which sociodemographic, blood glucose, urine albumin-to-creatinine ratio (ACR), and spot urine albumin data were collected. Multivariate logistic regression analyses (adjusted for age, sex, race/ethnicity, body mass index [BMI]) were used to identify clinical predictors of abnormal ACR (≥30 μg/mg) and abnormal spot urine albumin (>20 mg/L) levels.

Results: Among 1,190 NKFH-KEDS participants who met eligibility criteria, 13 and 49% had abnormal ACR and urine albumin levels, respectively. In multivariate logistic regression analyses, participants of older age (>65 years), Asian and Pacific Islander race/ethnicity, BMI ≥30 kg/m2, and with hypertension had higher risk of abnormal ACR. Being of older age; Asian, Pacific Islander, and Mixed race/ethnicity; and having diabetes was associated with higher risk of abnormal urine albumin levels in adjusted analyses.

Conclusions: NKFH-KEDS participants of older age; Asian and Pacific Islander race/ethnicity; and with obesity, hypertension, and diabetes had higher risk of kidney damage defined by elevated ACR and urine albumin levels. Further studies are needed to determine whether targeted screening programs can result in timely identification of CKD and implementation of interventions that reduce cardiovascular disease, death, and progression to end-stage renal disease.

Citing Articles

Behind the Smile: Detecting Chronic Kidney Disease Through Oral Health Screenings.

Fujimoto P, Wong K, Kataoka-Yahiro M Hawaii J Health Soc Welf. 2024; 83(9):260-262.

PMID: 39290534 PMC: 11402791. DOI: 10.62547/VYCO2960.


Racial Disparities in End-Stage Kidney Disease Outcomes among Asians and Native Hawaiians and Other Pacific Islanders across Geographic Residence.

You A, Norris K, Kataoka-Yahiro M, Davis J, Page V, Hayashida G Am J Nephrol. 2023; 55(1):115-126.

PMID: 37725913 PMC: 11745832. DOI: 10.1159/000534052.


Racial and Ethnic Differences in Chronic Kidney Disease and Its Risk Factors among Asian-Americans and Pacific Islanders in Hawaii.

Rhee C, You A, Page V, Hayashida G, Kataoka-Yahiro M, Davis J Nephron. 2023; 147(6):373-382.

PMID: 36603561 PMC: 10272063. DOI: 10.1159/000527990.


Early Identification of CKD-A Scoping Review of the Global Populations.

Okpechi I, Caskey F, Gaipov A, Tannor E, Noubiap J, Effa E Kidney Int Rep. 2022; 7(6):1341-1353.

PMID: 35685314 PMC: 9171699. DOI: 10.1016/j.ekir.2022.03.031.


Knowledge Gaps, Challenges, and Opportunities in Health and Prevention Research for Asian Americans, Native Hawaiians, and Pacific Islanders: A Report From the 2021 National Institutes of Health Workshop.

Kanaya A, Hsing A, Panapasa S, Kandula N, Araneta M, Shimbo D Ann Intern Med. 2022; 175(4):574-589.

PMID: 34978851 PMC: 9018596. DOI: 10.7326/M21-3729.


References
1.
Rhee C, Ahmadi S, Kalantar-Zadeh K . The dual roles of obesity in chronic kidney disease: a review of the current literature. Curr Opin Nephrol Hypertens. 2016; 25(3):208-16. PMC: 5926196. DOI: 10.1097/MNH.0000000000000212. View

2.
Amor A, Jimenez A, Moize V, Ibarzabal A, Flores L, Lacy A . Weight loss independently predicts urinary albumin excretion normalization in morbidly obese type 2 diabetic patients undergoing bariatric surgery. Surg Endosc. 2013; 27(6):2046-51. DOI: 10.1007/s00464-012-2708-3. View

3.
Hall Y, Hsu C, Iribarren C, Darbinian J, McCulloch C, Go A . The conundrum of increased burden of end-stage renal disease in Asians. Kidney Int. 2005; 68(5):2310-6. DOI: 10.1111/j.1523-1755.2005.00691.x. View

4.
Qaseem A, Hopkins Jr R, Sweet D, Starkey M, Shekelle P . Screening, monitoring, and treatment of stage 1 to 3 chronic kidney disease: A clinical practice guideline from the American College of Physicians. Ann Intern Med. 2013; 159(12):835-47. DOI: 10.7326/0003-4819-159-12-201312170-00726. View

5.
Kataoka-Yahiro M, Wong K, Tamashiro J, Page V, Ching J, Li D . Evaluation of the National Kidney Foundation of Hawai'i's Kidney Early Detection Screening program. Hawaii J Med Public Health. 2012; 71(7):186-92. PMC: 3392553. View